日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Hepatic HMGCS2-derived β-hydroxybutyrate attenuates hippocampal insulin resistance and neuroinflammation to promote MASLD-induced cognitive function

肝脏HMGCS2衍生的β-羟基丁酸酯可减轻海马胰岛素抵抗和神经炎症,从而促进MASLD诱导的认知功能。

Nie, Lijuan; Sun, Jing; Xu, Weilong; Yang, Xinyi; Wang, Gaoxiang; Wang, Ying; Jiang, Tao; Cao, Yutian; Chen, Hao; Xia, Qingrong; Zhou, Xiqiao

A review of treatment strategies for elderly patients with Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia

对费城染色体阴性B细胞急性淋巴细胞白血病老年患者治疗策略的回顾

Shi, Kaihang; Wang, Gaoxiang; Sun, Xueyan

Spatial transcriptomic characterization of the pathologic niche in a patient with pulmonary crystal-storing histiocytosis

肺晶体贮积性组织细胞增生症患者病理微环境的空间转录组学特征分析

Chen, Yao; Huang, Zhining; Wang, Gaoxiang; Wu, Mingsheng; Chen, Xiao; Sun, Xiaohui; Gao, Lei; Xie, Mingran

Dasatinib-resistant universal CAR-T cells proliferate in the presence of host immune cells and exhibit antitumor activity

达沙替尼耐药的通用型CAR-T细胞在宿主免疫细胞存在的情况下增殖并表现出抗肿瘤活性。

Cheng, Yuhang; Zhang, Jiayuan; Mu, Wei; Ye, Shanwei; Cheng, Jiali; Zhu, Li; Wang, Gaoxiang; Cao, Yang; Li, Dengju; Hu, Guang; Huang, Liang; Wang, Jue; Zhou, Jianfeng

Outcomes of acute myeloid leukemia with KMT2A (MLL) rearrangement: a multicenter study of TROPHY group

KMT2A(MLL)重排急性髓系白血病的预后:TROPHY组的一项多中心研究

Zhang, Ruoxuan; Huang, Huihong; Zhang, Yi; Xia, Yi; Huang, Jiayu; Jiang, Chuanhe; Wang, Luxiang; Lu, Haiyang; Pan, Zengkai; Wang, Gaoxiang; Yang, Yang; Ma, Yilei; Mo, Xiaodong; Shi, Wei; Hu, Xiaoxia; Cao, Yang

CAR T-cell therapy for relapsed/refractory CD5-positive diffuse large B-cell lymphoma yields more favorable outcomes than standard therapy

对于复发/难治性CD5阳性弥漫性大B细胞淋巴瘤,CAR-T细胞疗法比标准疗法疗效更佳。

Luo, Hui; Li, Tongjuan; Meng, Fankai; Hong, Zhenya; Cao, Yang; Wang, Gaoxiang; Huang, Liang; Zhou, Xiaoxi

Efficacy and safety comparison of CAR-T and blinatumomab immunotherapy as bridge-to-transplant strategies in relapsed/refractory B cell acute lymphoblastic leukemia

CAR-T 和 blinatumomab 免疫疗法作为复发/难治性 B 细胞急性淋巴细胞白血病移植桥接策略的疗效和安全性比较

Cao, Wenyue; Li, Ningwen; Wang, Gaoxiang; Xu, Hao; Yang, Yang; Wang, Jue; Xu, Jinhuan; Li, Yun; Zhang, Yicheng; Cao, Yang; Wang, Na

Efficacy and safety of a novel CD19, CD22 dual-targeted fully human loop bi-CAR-T for the treatment of relapsed/refractory B cell non-Hodgkin lymphoma

一种新型CD19、CD22双靶向全人源环状双CAR-T细胞疗法治疗复发/难治性B细胞非霍奇金淋巴瘤的疗效和安全性

Wang, Hanyu; Wang, Gaoxiang; Li, Tongjuan; Zhang, Peiling; Mao, Zekai; Luo, Hui; Zhu, Xiaojian; Li, Dengju; Zhou, Jianfeng; Zhou, Xiaoxi; Huang, Liang

Allogeneic transplantation in adverse-risk acute myeloid leukemia: Challenges, strategies, and future directions

高危急性髓系白血病异基因移植:挑战、策略和未来方向

Huang, Jingtao; Wu, Xinyi; Wang, Gaoxiang; Cao, Yang; Hu, Xiaoxia; Behalf Of Trophy Working Group, On

Targeting intracellular LMP2 with costimulatory signal-armed antibody-like TCR T cells

利用共刺激信号修饰的抗体样TCR T细胞靶向细胞内LMP2

Cheng, Jiali; Hu, Xuelian; Dai, Zhenyu; Zeng, Yuhao; Jin, Jin; Mu, Wei; Wei, Qiaoe; Jia, Xiangyin; Liu, Jianwei; Xie, Meng; Luo, Qian; Hu, Guang; Wang, Gaoxiang; Zhu, Xiaojian; Zhou, Jianfeng; Xiao, Min; Wang, Jue; Tan, Taochao; Huang, Liang